M
Min Su
Researcher at Central South University
Publications - 49
Citations - 1924
Min Su is an academic researcher from Central South University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 17, co-authored 36 publications receiving 907 citations.
Papers
More filters
Journal ArticleDOI
Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
Min Su,Yuhang Xiao,Junliang Ma,Yanyan Tang,Bo Tian,Yuqin Zhang,Xu Li,Zhining Wu,Desong Yang,Yong Zhou,Hui Wang,Qianjin Liao,Wenxiang Wang +12 more
TL;DR: Current knowledge regarding the functions ofcircRNAs in the hallmarks, stemness, resistance of cancer, as well as the possibility of circRNAs as biomarkers in cancer are summarized.
Journal ArticleDOI
Role of the NFκB-signaling pathway in cancer
Longzheng Xia,Shiming Tan,Yujuan Zhou,Jingguan Lin,Heran Wang,Linda Oyang,Yutong Tian,Lu Liu,Min Su,Hui Wang,Deliang Cao,Qianjin Liao +11 more
TL;DR: Current understanding of the NFκB-signaling pathway in cancer is updated and targeted therapies against effectors in oncogenic signaling have improved the outcomes of cancer patients.
Journal ArticleDOI
The cancer metabolic reprogramming and immune response.
Longzheng Xia,Linda Oyang,Jinguan Lin,Shiming Tan,Yaqian Han,Nayiyuan Wu,Pin Yi,Pin Yi,Lu Tang,Lu Tang,Qing Pan,Qing Pan,Shan Rao,Jiaxin Liang,Yanyan Tang,Min Su,Xia Luo,Yiqing Yang,Yingrui Shi,Hui Wang,Yujuan Zhou,Qianjin Liao +21 more
TL;DR: The overlapping metabolic reprogramming of cancer and immune cells is a putative determinant of the antitumor immune response in cancer Increased evidence suggests that cancer metabolism not only plays a crucial role in cancer signaling for sustaining tumorigenesis and survival, but also has wider implications in the regulation of the immune response through both the release of metabolites and affecting the expression of immune molecules, such as lactate, PGE2, arginine, etc.
Journal ArticleDOI
Cancer stem cells in progression of colorectal cancer.
Yu-juan Zhou,Longzheng Xia,Heran Wang,Linda Oyang,Min Su,Qiang Liu,Jingguan Lin,Shiming Tan,Yutong Tian,Qianjin Liao,Deliang Cao,Deliang Cao +11 more
TL;DR: This review article updates the colorectal CSCs with a focus on their role in tumor initiation, progression, drug resistance and tumor relapse.
Journal ArticleDOI
AKT and ERK dual inhibitors: The way forward?
TL;DR: The AKT and ERK signaling are both aberrantly activated in a wide range of human cancers and have long been targeted for cancer therapy, but the clinical benefits of these targeted therapies have been limited due to complex cross-talk.